NCT02462447View on ClinicalTrials.gov

Carbon-11 Labeled Sarcosine in Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

February 8, 2017

Study Completion Date

February 8, 2017

Conditions
Prostate Cancer
Interventions
DRUG

11C-sarcosine

Radiotracer injection for PET/CT scan

DRUG

11C-choline

Radiotracer injection for PET/CT scan

Trial Locations (1)

48109

University of Michigan Health Systems, Ann Arbor

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Michigan

OTHER

NCT02462447 - Carbon-11 Labeled Sarcosine in Prostate Cancer | Biotech Hunter | Biotech Hunter